Moderna Lauds Joint Work With Health Authorities On Spikevax Safety Monitoring

 
• By Vibha Sharma

A senior executive at Moderna recounts how the company used a variety of data sources to identify potential safety signals for its Spikevax COVID-19 vaccine during a state of “hyper-pharmacovigilance.”

Concept of safety of corona virus vaccination
Sponsors reviewed and reported COVID-19 vaccine safety data more frequently • Source: Shutterstock

More from Drug Safety

More from Pink Sheet